Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Zhu, Lina | Chen, Yinanb | Nie, Kaic | Xiao, Yongxinc | Yu, Honga; *
Affiliations: [a] Department of Radiology, Dongfang Hospital Affiliated to Shanghai Tongji University, Shanghai, China | [b] Department of Radiology, Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University, Shanghai, China | [c] Department of Radiology, Shanghai Changzheng Hospital Affiliated to the Second Military Medical University, Shanghai, China
Correspondence: [*] Corresponding author: Hong Yu, Dongfang Hospital Affiliated to Shanghai Tongji University, No. 150 Jimo Road, Shanghai 310000, China. Tel.: +86 021 38804518; E-mail: ies620284@163.com.
Abstract: MiRNAs regulated most genes expression, which were proved important in various tumors. In this study, we want to investigate miR-101 effect and molecular mechanism on pancreatic cancer (PC), the research about this was blank now. RT-PCR analysis showed that miR-101 expression was declined in PC. MTT assay found that miR-101 mimic suppressed cell viability, while suppressing miR-101 facilitated cell proliferation. Transwell assay showed that miR-101 mimic inhibited cell invasion, but promoted cell invasion by miR-101 inhibitor. With TargetScanHuman’s help, we verified STMN1 as a specific target of miR-101 and luciferase reporter assay was carried out to further confirm this discovery. STMN1 expression was reduced by miR-101 mimic and increased by miR-101 inhibitor. We next found that STMN1 was elevated in PC and its expression was negatively correlated with miR-101 expression. Furthermore, STMN1 siRNA curbed cell proliferation and invasion, which was opposite to miR-101 inhibitor effect on PC progression and STMN1 siRNA attenuated miR-101 inhibitor effect on cell proliferation and invasion. In conclusion, miR-101 inhibited PC cell proliferation and invasion via regulating STMN1, which provided a potential therapeutic for PC patients.
Keywords: MiR-101, pancreatic cancer, STMN1, proliferation, invasion
DOI: 10.3233/CBM-181675
Journal: Cancer Biomarkers, vol. 23, no. 2, pp. 301-309, 2018
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl